| Ibrutinib investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 112show all (up to 200) |
|---|
| → investigated in trials for | Chronic Lymphocytic Leukemiahematologic_malignancy 86 trials (32 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Chronic Lymphocytic Leukemia | 86 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mantle Cell Lymphomahematologic_malignancy 59 trials (18 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Mantle Cell Lymphoma | 59 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Small Lymphocytic Lymphoma 50 trials (22 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Small Lymphocytic Lymphoma | 50 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leukemia 25 trials (5 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Leukemia | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Diffuse Large B-Cell Lymphoma 23 trials (8 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Diffuse Large B-Cell Lymphoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Waldenstrom Macroglobulinemiahematologic_malignancy 22 trials (6 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Waldenstrom Macroglobulinemia | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Follicular Lymphomahematologic_malignancy 19 trials (4 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Follicular Lymphoma | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Non-Hodgkin Lymphomahematologic_malignancy 17 trials (7 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Non-Hodgkin Lymphoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lymphomacancer_family 15 trials (5 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Lymphoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Marginal Zone Lymphoma 12 trials (5 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Marginal Zone Lymphoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Grade 1 Follicular Lymphoma 10 trials (4 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Grade 1 Follicular Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Grade 2 Follicular Lymphoma 10 trials (4 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Grade 2 Follicular Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | B-Cell Malignant Neoplasm 9 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | B-Cell Malignant Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Primary Central Nervous System Lymphoma 9 trials (4 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Primary Central Nervous System Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Multiple Myeloma 7 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Multiple Myeloma | 7 | Observed | clinicaltrials | graph → |